R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

The role of a Research Consulting Organisation in educating ...

How can RCOs help biotech, pharma, and device innovators bring life-saving drugs to market sooner and more cost effectively?

R&D

The race for gold: Closing in on the first RSV vaccine

The industry looks set to bring the first vaccine for RSV to market in the coming year. But, which companies are leading the race, and why it would mark an important development for global health?

R&D

Is biotech ready for the lecanemab opportunity?

The US Veterans Health Administration recently announced that it will cover the cost of Biogen’s lecanemab for veterans suffering from early stages of Alzheimer’s disease.

R&D

Making accessibility strategy part of your rare disease tria...

Over the past several years, diversity, equity, and inclusion (DEI) has become a central subject of conversation in clinical trials.

R&D

Why Ireland has emerged as Europe’s biopharma hotspot

Ireland is attracting major investment from the largest pharma companies in the world.

R&D

Creating healthier futures - Reuters Pharma Barcelona 2023

In this latest mini pharmaphorum podcast, web editor Nicole Raleigh spoke with Tommy Bramley, SVP of global consulting at Amerisource Bergen, whilst attending Reuters Pharma Barcelona.